Aldose reductase inhibitory activity and antioxidant capacity of pomegranate extracts
By: Çimen Karasu, Ahmet Cumaoğlu, Ali Gúrpinar, Murat Kartal, Lucia Kovacikova, Ivana Milackova and Milan Stefek
Open Access
|May 2012References
- Alexiou P, Pegklidou K, Chatzopoulou M, Nicolaou I, Demopoulos VJ. (2009). Aldose reductase enzyme and its implication to major health problems of the 21(st) century.: 734-752.
- Artik N. (1998). Determination of phenolic compounds in pomegranate juice by using HPLC.: 492-499
- Bagri P, Ali M, Aeri V, Bhowmik M, Sultana S. (2009). Antidiabetic effect of Punica granatum flowers: effect on hyperlipidemia, pancreatic cells lipid peroxidation and antioxidant enzymes in experimental diabetes.: 50-54.
- Bell C, Hawthorne S. (2008). Ellagic acid, pomegranate and prostate cancer - a mini review.: 139-144.
- Blois, M. S. (1958). Antioxidant determinations by the use of a stable free radical.: 1199-1200.
- Cerda B, Espin JC, Parra S, Martinez P, Tomas-Barberan FA. (2004). The potent in vitro antioxidant ellagitannins from pomegranate juice are metabolised into bioavailable but poor antioxidant hydroxy-6H-dibenzopyran-6-one derivatives by the colonic microflora of healthy humans.: 205-220.
- Chidambara Murthy KN, Jayaprakasha GK, Singh RP. (2002). Studies on antioxidant activity of pomegranate (Punica granatum) peel extract using in vivo models.: 4791-4795.
- Constantino L, Rastelli G, Gamberini MC, (1999). 1-Benzopyran-4-one antioxidants and aldose reductase inhibitors.: 1881-1893.
- Coudert P, Albuisson E, Boire JY, Duroux E, Bastide P, Couquelet J. (1994). Synthesis of pyridazine acetic acid derivatives possessing aldose reductase inhibitory activity and antioxidant properties.: 471-477.
- Das AK, Mandal SC, Banerjee SK, Sinha S, Saha BP, Pal M. (2001). Studies on the hypoglycaemic activity of Punica granatum seed in streptozotocin induced diabetic rats.: 628-629.
- Da Settimo F, Primofiore G, La Motta C, Sartini S, Taliani S, Simorini F, Marini AM, Lavecchia A, Novellino E, Boldrini E. (2005). Naphtho[1,2-d]isothiazole acetic acid derivatives as a novel class of selective aldose reductase inhibitors.: 6897-907.
- Del Corso A, Cappiello M, Mura U. (2008). From a dull enzyme to something else: facts and perspectives regarding aldose reductase.: 1452-1461.
- Dikmen M, Ozturk N, Ozturk Y. (2011). The antioxidant potency of Punica granatum L. Fruit peel reduces cell proliferation and induces apoptosis on breast cancer.:1638-46.
- El Kar C, Ferchichi A, Attia F, Bouajila J. (2011). Pomegranate (Punica granatum) juices: chemical composition, micronutrient cations, and antioxidant capacity.: C795-C800.
- Gil MI, Tomas-Barberan FA, Hess-Pierce B, Holcroft DM, Kader AA. (2000). Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing.: 4581-4589.
- Hamada Y, Araki N, Horiuchi S, Hotta N. (1996). Role of polyol pathway in nonenzymatic glycation.(Suppl): 95-98.
- Hayman S, Kinoshita JH. (1965). Isolation and properties of lens aldose reductase.: 877-882.
- Han DH, Lee MJ, Kim JH. (2006). Antioxidant and apoptosis-inducing activities of ellagic acid.: 3601-3606.
- Hontecillas R, O'Shea M, Einerhand A, Diguardo M, Bassaganya-Riera J. (2009). Activation of PPAR gamma and alpha by punicic acid ameliorates glucose tolerance and suppresses obesity-related inflammation.: 184-195.
- Huang TH, Peng G, Kota BP, Li GQ, Yamahara J, Roufogalis BD, Li Y. (2005). Anti-diabetic action of Punica granatum flower extract: activation of PPAR-gamma and identification of an active component.: 160-169.
- Jafri MA, Aslam M, Javed K, Singh S. (2000). Effect of Punica granatum Linn. (flowers) on blood glucose level in normal and alloxan-induced diabetic rats.: 309-314.
- Joseph MM, Aravind SR, Varghese S, Mini S, Sreelekha TT. (2011). Evaluation of antioxidant, antitumor and immunomodulatory properties of polysaccharide isolated from fruit rind of Punica granatum.doi: 10.3892/mmr.2011.638. [Epub ahead of print].
- Juranek I, Horakova L, Rackova L, Stefek M. (2009). Antioxidants in treating pathologies involving oxidative damage: an update on medicinal chemistry and biological activity of stobadine and related pyridoindoles.: 552-570.
- Jurenka JS. (2008). Therapeutic applications of pomegranate (Punica granatum L.): a review.: 128-144.
- Kador PF. (1998). The role of aldose reductase in the development of diabetic complications.: 325-352.
- Kador PF, Lee JW, Fujisawa S, Blessing K, Lou MF. (2000). Relative importance of aldose reductase versus nonenzymatic glycosylation on sugar cataract formation in diabetic rats.: 149-160.
- Katz SR, Newman RA, Lansky EP. (2007). Punica granatum: heuristic treatment for diabetes mellitus.: 213-217.
- Kinoshita JH. (1990). A thirty-year journey in the polyol pathway.: 567-573.
- Kyselova Z, Stefek M, Bauer V. (2004). Pharmacological prevention of diabetic cataract.: 129-140.
- Kulkarni AP, Aradhya SM, Divakar S. (2004). Isolation and identification of a radical scavenging antioxidant-punicalagin from pith and carpellary membrane of pomegranate fruit.: 551-557.
- Lansky EP. (2006). Beware of pomegranates bearing 40% ellagic acid.: 119-122.
- Lansky EP, Newmana RA. (2007). Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer.: 177-206.
- Li Y, Qi Y, Huang TH, Yamahara J, Roufogalis BD. (2008). Pomegranate flower: a unique traditional antidiabetic medicine with dual PPAR-alpha/-gamma activator properties.: 10-17.
- Li Y, Wen S, Kota BP, Peng G, Li GQ, Yamahara J, Roufogalis BD. (2005). Punica granatum flower extract, a potent alpha-glucosidase inhibitor, improves postprandial hyperglycemia in Zucker diabetic fatty rats.: 239-244.
- Mihaljevic B, Katusin-Razem B, Razem B. (1996). The reevaluation of the ferric thiocyanate assay for lipid hydroperoxides with special considerations of the mechanistic aspects of the response.: 53.
- Naz S, Siddiqi R, Ahmad S, Rasool SA, Sayeed SA. (2007). Antibacterial activity directed isolation of compounds from Punica granatum.: M341-M345.
- Negi PS, Jayaprakasha GK, Jena BS. (2003). Antioxidant and antimutagenic activities of pomegranate peel extracts.: 393-397.
- Oates PJ. (2008). Aldose reductase, still a compelling target for diabetic neuropathy.: 14-36.
- Obrosova IG. (2005). Increased sorbitol pathway activity generates oxidative stress in tissue sites for diabetic complications.: 1543-1552.
- Rout S, Banerjee R. (2007). Free radical scavenging, anti-glycation and tyrosinase inhibition properties of a polysaccharide fraction isolated from the rind from Punica granatum.: 3159-3163.
- Scott JA, King GL. (2004). Oxidative stress and antioxidant treatment in diabetes.: 204-213.
- Seeram NP, Adams LS, Henning SM, Niu Y, Zhang Y, Nair MG, Heber D. (2005). In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice.: 360-367.
- Singh RP, Chidambara Murthy KN, Jayaprakasha GK. (2002). Studies on the antioxidant activity of pomegranate (Punica granatum) peel and seed extracts using in vitro models.: 81-86.
- Stefek M. (2011). Natural flavonoids as potential multifunctional agents in prevention of diabetic cataract.: 101-109.
- Stefek M, Karasu C. (2011). Eye lens in aging and diabetes. Effect of quercetin.: 525-534.
- Stefek M, Snirc V, Djoubissie PO, Majekova M, Demopoulos V, Rackova L, Bezakova Z, Karasu C, Carbone V, El-Kabbani O. (2008). Carboxymethylated pyridoindole antioxidants as aldose reductase inhibitors: Synthesis, activity, partitioning, and molecular modeling.: 4908-4920.
- Sun Hui, Jia Dong-ying, Yao Kai. (2008). inhibitory effect of polyphenol extract from pomegranate peel on aldose reductase activity.(3): 508-510.
- Ueda H, Kawanishi K, Moriyasu M. (2004). Effects of ellagic acid and 2-(2,3,6-trihydroxy-4-carboxyphenyl)ellagic acid on sorbitol accumulation in vitro and in vivo Biol.: 1584-1587.
- Walid Elfalleh, Nizar Tlili, Nizar Nasri, Yassine Yahia, Hedia Hannachi, Nizar Chaira, Ma Ying, Ali Ferchichi. (2011). Antioxidant capacities of phenolic compounds and tocopherols from tunisian pomegranate (Punica granatum).: C707-C713.
- Wang R, Ding Y, Liu R, Xiang L, Du L. (2010). Pomegranate: constituents, bioactivities and pharmacokinetics.Special Issue: 77-87.
- Yabe-Nishimura C. (1998). Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications.: 21-33.
- Zahin M, Aqil F, Ahmad I. (2010). Broad spectrum antimutagenic activity of antioxidant active fraction of punica granatum L. peel extracts.: 99-107.
Language: English
Page range: 15 - 20
Published on: May 11, 2012
Published by: Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
In partnership with: Paradigm Publishing Services
Related subjects:
© 2012 Çimen Karasu, Ahmet Cumaoğlu, Ali Gúrpinar, Murat Kartal, Lucia Kovacikova, Ivana Milackova, Milan Stefek, published by Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
This work is licensed under the Creative Commons License.